December 22, 2011 ·
1 comment
Clients and Friends,
After another successful year, we wish you a holiday season filled with joy and fun times with family and friends.
The month of December causes many to reflect on the successes and challenges they have experienced throughout the year, and we’re no different. In any business, you win some and you lose some, but we find ourselves very thankful for all of the new friends we’ve made this year and the times we’ve shared with old friends, too.
Our work remains more fulfilling than ever, even with the constant ratcheting of regulation and legislation in the industry we serve. This increasing scrutiny demands that we bring our “A game,” keeping our clients ethical and compliant in all that they do with thought leaders and centers of excellence.
We hope all of you, as you take time to reflect this year, have as many reasons to be thankful as we do. We are grateful for your business, your friendships, and your continued faith in us.
Happy Holidays from all of us at Thought Leader Select.
TAGS: 
centers of excellence compliance healthcare legislation healthcare reform healthcare regulations Holidays key opinion leaders medical ethics Thought Leader Select thought leaders
December 6, 2011 ·
Leave a comment
Industry Insights from Paul Meade, M. Sc, MPH
For every transaction over ten dollars paid to a physician by a pharmaceutical manufacturer, the Physician Payments Sunshine Provision demands disclosure to a database that will be made public in 2013.
Notwithstanding the absurdity of collecting such an enormous amount of information, someone will undoubtedly spend a lot of time sifting through this data to create lists of “worst offenders.” These lists will be publically promulgated with the sole purpose of bestowing shame on these so-called “offenders.”
Of course, these lists may be perceived as tantamount to publishing a list of child molesters moving into a new neighborhood, or those people charged with driving under the influence of alcohol over the weekend listed in the Monday newspaper. Some of the most brilliant and renowned physicians in this country will be brought to shame for consulting with some manufacturers.
So, how bad can it get? Well, let’s imagine the following scenario, which I refer to as Grinding to a Halt. Leaders in the medical community who are respected for their research and experience may become so concerned about being publically exposed for consulting with various manufacturers that they may decide to cease all interactions going forward.
There will be no more advising pharmaceutical companies about the unmet medical needs for new molecules discovered in their research laboratories. There ... read more »
TAGS: academic medical centers capitation centers of excellence clinical studies CME continuing medical education drug compounds drug manufacturers healthcare reform medical community medical conferences pharmaceuticals Physician Payments Sunshine Provision physicians research laboratories Sunshine Act
December 2, 2011 ·
Leave a comment
Thought Leader Select is pleased to announce a series of key opinion leader (KOL) identification and profiling projects to support multiple therapeutic areas for a top five global biopharmaceutical company.
In these research assessments, Thought Leader Select will identify and profile leading medical experts in neurology and oncology to support drug development initiatives in various cancers and neurological disorders. The oncologists and neurologists will represent many of the leading physicians at top medical centers of excellence throughout Canada.
Thought Leader Select will use its validated, objective deep profiling methodology to assess the skills and experience of the thought leaders in oncology and neurology in multiple research categories, including their areas of expertise, medical/scientific journal publishing history, and participation in basic and clinical research. The company’s research group is comprised of subject-matter experts in medicine, with decades of experience working in medical research and clinical settings in the United States, Canada, Australia, and Africa.
The project will yield over 100 physicians who may advise the company on its development efforts in the treatment of cancers and neurological diseases. Typically, key opinion leaders serve on scientific advisory boards and participate in late-stage clinical trials to monitor the effectiveness of new drugs in larger patient populations.
“We are honored that this company has chosen to partner with us again to use effective solutions to identify ... read more »
TAGS: basic research biopharmaceutical cancer treatment cancers clinical research clinical trials deep-profiling doctors drug development key opinion leaders KOL identification KOL profiling late-stage clinical trials medical experts medical journals medical research medicine neurological disorders neurology oncologists Oncology patient populations pharmaceuticals physicians prescription drugs scientific journals therapeutic areas Thought Leader Select thought leaders
